Podcasts about Ramanan Laxminarayan

Send us a textIt's been a dire year for global health. Almost as soon as he took office as president of the United States, Donald Trump said he would withdraw the country from membership in the World Health Organization (WHO), he fired almost everyone at the U.S. Agency for International Development (USAID), and slashed staffing and budgets at U.S. health agencies such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). The United States government also says it plans to end funding for Gavi, the Vaccine Alliance, and has cut some funding for the United Nations World Food Program's efforts to feed millions of people in 14 countries.Before Trump, the United States was the largest donor to global health in the world, contributing about US$12 billion in funding. That's less than 1 percent of the United States federal budget. But the new administration claimed these efforts were wasteful, did not serve the country's interests, and cost too much. It's not clear who can or will fill the gaps.“I think we are going through a very dark time,” says Dr. Ramanan Laxminarayan, founder and president of the One Health Trust. But Dr. Laxminarayan, an epidemiologist and economist, does see some hope. He doubts the United States will permanently end its robust support of global health and he sees opportunities for organizations such as WHO to streamline and become more efficient.Listen as he chats with One World, One Health host Maggie Fox about the immediate effects of the startling new United States government policies and how he sees things shaking out in the long term.

Ramanan Laxminarayan is the founder and president of the One Health Trust, Director of the WHO Collaborating Center on Antimicrobial Resistance in New Delhi, India, and an Affiliate Professor at the University of Washington, Seattle, WA. He is the lead author of The Lancet's May 2024 series on Sustainable Access to Antibiotics. He joins Gavin and Jessamy to discuss how big of a problem AMR currently is and will be, what is being done, and what needs to be done.Read the Series here:https://www.thelancet.com/series/antibiotic-resistance?dgcid=buzzsprout_tlv_podcast_generic_lancetSend us your feedback!Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

What kills more people than HIV or malaria? What threatens anybody on the planet – and not just people, but animals, too?It's antimicrobial resistance (AMR), the formal name for drug-resistant superbugs. These include bacteria that defy the effects of antibiotics, viruses that thrive in the face of antiviral drugs, and fungi that are immune to antifungal treatments.Each year, an estimated 7.7 million deaths are caused by bacterial infections, and nearly 5 million of these deaths are associated with drug-resistant bacteria. These infections include newborn babies, the elderly, and cancer patients, but also people who were young, fit, and healthy before they got infected.AMR is a major topic of discussion this year (2024) for the World Health Organization and it will take top billing at the United Nations General Assembly. To set the tone for all the discussion, the Lancet has published a series of four papers reviewing the problem and laying out some of the solutions. For the series, the One Health Trust's Dr. Ramanan Laxminarayan brought together experts from around the world to address the issue. Dr. Iruka Okeke of the Department of Pharmaceutical Microbiology at the University of Ibadan in Nigeria helped write the first of these papers. Dr. Okeke, a bacterial geneticist, points out that antimicrobial-resistant infections can happen anywhere – in hospital patients, in people leading their everyday lives, in farm animals, and in nature among wildlife.It's important to use antibiotics and other antimicrobial drugs properly, but also to make sure that people who need them can get the right antibiotics at the right time. It's especially important to keep an eye out for these drug-resistant superbugs, she said. Surveillance helps doctors know whether patients coming in can be treated with everyday antibiotics, or if they need special, usually more expensive, drugs.Skipping surveillance, she says in this episode of One World, One Health, is like playing tennis without keeping score. “If you play tennis and you are not keeping score, you are just practicing.”Listen as Dr. Okeke explains why we all need to do a better job watching out for these killer germs.Read more about the One Health Trust's work on antimicrobial resistance here.

Air – it's our most basic need. It's far more vital than water, food, or medicine. People can survive just minutes without its most important component: oxygen. But in much of the world, people struggling to breathe lack access to medical oxygen, a treatment that makes the difference between life and death. The COVID-19 pandemic highlighted the problem and made it exponentially worse. “I will never forget the images,” Leith Greenslade, coordinator of the Every Breath Counts coalition, tells us on the One World, One Health podcast. “Patients suffocating to death as hospitals ran out of oxygen.” A team at the University of Washington estimates that 25 million people die every year of both acute and chronic conditions that need treatment with medical oxygen. “It's unclear exactly how many of the estimated seven million COVID-19 deaths could have been prevented with adequate supplies of medical oxygen, but a study of COVID-19 deaths in African intensive care units found that half of patients died without ever receiving it,” Greenslade and the One Health Trust's Ramanan Laxminarayan wrote in a recent article. “Shamefully, world leaders have turned a blind eye to the lack of access to medical oxygen.” Listen as Leith explains the scope of the problem and the possible solutions in this episode of One World, One Health. 

This podcast is a commentary and does not contain any copyrighted material of the reference source. We strongly recommend accessing/buying the reference source at the same time. ■Reference Source https://www.ted.com/talks/ramanan_laxminarayan_the_coming_crisis_in_antibiotics ■Post on this topic (You can get FREE learning materials!) https://englist.me/147-academic-words-reference-from-ramanan-laxminarayan-the-coming-crisis-in-antibiotics-ted-talk/ ■Youtube Video https://youtu.be/_5fs0_g6gzE (All Words) https://youtu.be/9gMmVh1zYb4 (Advanced Words) https://youtu.be/xtoV37WfZJI (Quick Look) ■Top Page for Further Materials https://englist.me/ ■SNS (Please follow!)

Everyone's heard the saying about how a butterfly flapping its wings in China can cause a hurricane half a world away. In this episode, we chat with One Health Trust (OHT) Founder and President Dr. Ramanan Laxminarayan about how OHT's new center in the Nimai Valley outside Bangalore, India, will incorporate this idea into its design and intent. Butterflies are fragile, but vital pollinators, and they can represent how interconnected the world is.So will the Nimai Valley Center, which will be entirely powered by solar energy, will collect its own water, and produce organic foods onsite to help feed researchers, students, and guests from around the world. The hope is to create a space where people can apply One Health concepts to solving the problems of new and old diseases, poor diet, and climate change. The idea is as ancient as the civilizations of South Asia, China, Africa, and the Americas and as modern as the science showing disrupting the environment can fuel the spread of disease, says Ramanan.

Superbugs develop their resistance to antibiotics by mixing and mingling with each other. Many superbugs travel on and in our bodies as we go back and forth overseas. But that isn't the only way they move. In this episode we find out how superbugs spread in surprising ways and are found in the most remote locations. We find out why some countries are hotspots for resistance and what happens if you become infected with a superbug while travelling.Have a look at ResistanceMap, where you can see interactive world maps of antibiotic resistance by pathogen and antibiotic use by type in every country.Here is a link to Dr Isabel Frost's study:Isabel Frost, DPhil, Thomas P Van Boeckel, PhD, João Pires, PhD, Jessica Craig, BA, BS, Ramanan Laxminarayan, PhD, Global geographic trends in antimicrobial resistance: the role of international travel, Journal of Travel Medicine, Volume 26, Issue 8, 2019, taz036, https://doi.org/10.1093/jtm/taz036This article from 2019 in the New York Times about superbugs in India's River Ganges, using powerful photography to capture this issue.Read about the Beach Bums Survey on antibiotic resistant E. coli in the guts of surfers versus non-surfers here.Find out why antibiotic resistance is a particularly big challenge in remote Indigenous communities in this article in The Conversation.Interviewees in this episode:Surfer Ian Cohen, who is also a climate change activist and speaker on environmental issues.Dr Isabel Frost, who was working in India for the Centre for Disease Dynamics and Policy, and is now working as a consultant for the World Health Organisation. She's also part of the Antimicrobial Resistance Fighter Coalition.AMR activist David Mateo Ricci, who also wrote this piece about his experience contracting a resistant infection in India.Chennai-based infectious diseases specialist Dr Abdul Ghafur, coordinator of the Chennai Declaration on antimicrobial resistance in developing countries.Gomis Rugamba, a documentary photographer and visual artist born in the Democratic Republic of the Congo, grew up in Rwanda and now living in Australia.Host and producer: Dr Britta Jorgensen. Producers: Sarah Mashman and Silvi Vann-Wall. Executive Producer: Professor Mia Lindgren.

When will the Third Wave of Covid hit India and how bad will it be? Spoke to Dr. Varsha Sridhar and she broke it all down so beautifully. This evening(8.07.2021).. NCBS is holding a webinar on predicting and mitigating the possible third wave of COVID at macro and micro levelss. This becomes critical as we re-invent public health training and structures for the future. Dr. Varsha Sridhar, a Bangalore-based molecular virologist will discuss ongoing and emerging COVID surveillance strategies and challenges. Prof. Vikram Patel, a psychiatrist and global health expert will discuss institutional structures and potential rewiring of public health programs. Prof. Ramanan Laxminarayan, a disease dynamics expert, will engage with the role of models, dealing with complex trade-offs in decision making in pandemics and beyond. The discussion will be moderated by Prof. Sudhir Krishna (NCBS-TIFR and IIT-Goa), the Covid-Gyan webinar series is hosted by Prof. Uma Ramakrishnan, NCBS-TIFR. --- Send in a voice message: https://anchor.fm/gmbwithkay/message

By 2050, experts predict that 10 million people will die of antibiotic-resistant infections—surpassing deaths from cancer. As the world continues to rebuild from the pandemic, it's more critical than ever that we address this growing crisis. Together we can work to strengthen our food systems and reduce the misuse of antibiotics. Event brought to you by Food Tank and Applegate. —Lena Brook, the Director of Food Campaigns, Healthy People & Thriving Communities Program at the Natural Resources Defense Council —Tiffany Derry, an American chef well-known for her appearances on Top Chef —John Ghingo, the CEO of Applegate, a natural and organic meat brand —Joel Gindo, who runs Free Happy Farm in South Dakota, where he raises pigs —Ramanan Laxminarayan, the Founder and Director of the Center for Disease Dynamics, Economics & Policy —Ron Mardesen, a fifth-generation family farmer at A-Frame Acres in Iowa —Lance Price, a professor at George Washington University's Milken Institute School of Public Health and the Founding Director of GW's Antibiotic Resistance Action Center. Moderated by Jane Black, who is a nationally known food writer and journalist, and myself. After two years of declines, the number of antibiotics given to animals is rising, according to recent U.S. Food and Drug Administration (FDA) research. Antibiotic resistance is a global health crisis, and it's fueled by the overuse of antibiotics in livestock. In fact, more than 80% of antibiotics sold in the U.S. go to farm animals. And that number is growing: Sales jumped 11% between 2017 and 2019, according to the FDA.

India is seeing a decline in the second wave of coronavirus infections, but a rare and deadly fungal infection is affecting patients recovering from Covid. India has reported more than 11,000 cases of the black fungus infection, also known as mucormycosis. It has a mortality rate of over 50 per cent, and the drug needed for its treatment is in short supply. Missing a dose can result in removal of tissues or, in serious cases, bones and even the eye. Doctors say there is a link between black fungus and indiscriminate use of steroids to treat Covid patients. Diabetics are said to be particularly at risk. So, what are the treatment challenges, and what is happening to the families of patients faced with the double stress of health and finances? In this edition of WorklifeIndia, we discuss what can be done to tackle India's black fungus crisis. Presenter: Devina Gupta Contributors: Dr Akshay Nair, oculoplastic surgeon; Dr Ramanan Laxminarayan, founder and director, Centre for Disease Dynamics; Iqra Khalid, lawyer, black fungus patient's kin

As Covid cases surge almost beyond belief in India, how much is to do with social distancing, and how much to do with the mutations to the original virus? Ramanan Laxminarayan talks to Roland from Delhi about ways in which the huge second wave could and could not have been predicted and avoided. Suggestions of the latest variant to make the headlines, B1.617, have got virologists such as Ravindra Gupta working hard to identify the clinical significance of the latest combinations of mutations. In the journal Science, Stephen Chanock of the US Cancer program reports work with colleagues in Ukraine looking at the long footprint of radiation dosing from the Chernobyl nuclear disaster, 35 years ago this week. In the first of two papers, they find a definite footprint of radiation damage accounting for the many sad cases of thyroid cancer in people alive in the region at the time. But in another study, they looked at whether any higher level of mutations could be detected in the germlines of children conceived subsequently to parents who had experienced radiation in the disaster. While the parents' own health is often affected, 35 years on, thus far their offspring show no widespread elevated levels of disease, as was commonly expected. And in the week that the world witnessed a guilty verdict delivered in the trial for the murder of George Floyd in the US, David Curtis of the University of Utah and colleagues report in the journal PNAS a study that suggests the widespread media coverage of acts of racial violence, including deaths at the hands of police, leads to poorer mental health in Black Americans. As the BBC’s Samara Linton reports, the study involved google search data over five years up to 2017, and nearly 2.3 million survey respondents. Also, most of us don’t like to dwell on our toilet habits, but this week we have gone down the drain to discover what wastewater can tell us about our health. It’s been more than a year since scientists across the globe started to track the spread of Covid-19, with help from home test results and hospital data. Marnie Chesterton investigates the latest tool in their arsenal: sewage. Listener Kevin has heard how human waste can be monitored to check for virus levels, and wants to know if it can also be used to stop the disease in its tracks? Although the coronavirus has been discovered in people’s poo, so far there’s little indication it’s actually being spread through the water system. But by taking regular samples from different parts of cities, authorities are now able to accurately predict a local peak weeks before the population shows signs of sickness, then take immediate measures to alert them. In Detroit we hear how environmental engineer Professor Irene Zagoraraki used this method to detect a rare strain of Herpes which doctors didn’t even know was a potential problem. We talk to Professor Nick Thomson from the Wellcome Sanger Institute, who sequenced the genome of the bacteria that causes cholera, to understand how it has crisscrossed the globe. He discovered that the pandemic currently devastating Yemen actually originated in Asia. It’s a discovery that has changed how the WHO is thinking about this killer disease and could have important implications for vaccination programmes. But our effluent can also pose environmental problems, and Professor Andrew Johnson from the UK’s Centre for Ecology and Hydrology explains there are now as many as 300,000 chemicals that could threaten natural habitats. While authorities try to test each one individually, he’s concerned they may have different effects when they mix in wastewater, and current monitoring systems don’t take this into account. Not only that, but some of these substances contain silver nanoparticles, which Professor Juliane Filser tells us stick around in soil for ever, threatening organisms and bacteria at the base of the food chain Image: NurPhoto/Getty Images

This week, India set grim and global new high records Thursday with 315,000 cases in just 24 hours and another 2,100 deaths -- the highest one day number of new COVID-19 infections of any nation since the pandemic began. The country's already stressed health care system is overwhelmed. Amna Nawaz speaks to epidemiologist Ramanan Laxminarayan about the situation and the Indian government's response. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

This week, India set grim and global new high records Thursday with 315,000 cases in just 24 hours and another 2,100 deaths -- the highest one day number of new COVID-19 infections of any nation since the pandemic began. The country's already stressed health care system is overwhelmed. Amna Nawaz speaks to epidemiologist Ramanan Laxminarayan about the situation and the Indian government's response. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

As Covid cases surge almost beyond belief in India, how much is to do with social distancing, and how much to do with the mutations to the original virus? Ramanan Laxminarayan talks to Roland from Delhi about ways in which the huge second wave could and could not have been predicted and avoided. Suggestions of the latest variant to make the headlines, B1.617, have got virologists such as Ravindra Gupta working hard to identify the clinical significance of the latest combinations of mutations. In the journal Science, Stephen Chanock of the US Cancer program reports work with colleagues in Ukraine looking at the long footprint of radiation dosing from the Chernobyl nuclear disaster, 35 years ago this week. In the first of two papers, they find a definite footprint of radiation damage accounting for the many sad cases of thyroid cancer in people alive in the region at the time. But in another study, they looked at whether any higher level of mutations could be detected in the germlines of children conceived subsequently to parents who had experienced radiation in the disaster. While the parents' own health is often affected, 35 years on, thus far their offspring show no widespread elevated levels of disease, as was commonly expected. And in the week that the world witnessed a guilty verdict delivered in the trial for the murder of George Floyd in the US, David Curtis of the University of Utah and colleagues report in the journal PNAS a study that suggests the widespread media coverage of acts of racial violence, including deaths at the hands of police, leads to poorer mental health in Black Americans. As the BBC’s Samara Linton reports, the study involved google search data over five years up to 2017, and nearly 2.3 million survey respondents. Image: NurPhoto/Getty Images Presenter: Roland Pease Reporter: Samara Linton Producer: Alex Mansfield

Co-hosts Larry Bernstein and Mitch Feinman welcome the following guests for the 11.22.2020 show of What Happens Next: Sam Hoffman, Phil Abraham, James Gray, Josh Goldstine, Tom Cotton, Ramanan Laxminarayan, and Richard Levitan.

Ramanan Laxminarayan, economist, epidemiologist and founder and director of the Center for Disease Dynamics, Economics & Policy (CDDEP), talks about how the COVID-19 pandemic has played out in India, which is on track to surpass the United States as the country with the most cases worldwide — plus in other places around world, including Israel, which recently instituted a second full lockdown.

Kiran Mazumdar-Shaw, Chairperson - Biocon and Dr. Ramanan Laxminarayan, Founder & Director - Center for Disease Dynamics, Economics & Policy (CDDEP) speak to Business Insider's Sriram Iyer on how India should approach healthcare issues in the post-COIVID world.

The Covid-19 pandemic has placed uncertainty at the forefront. When will cases peak? What kind of a recovery will we see? Will shuttered economies be able to reopen? Amid this global guessing game, we speak to Ramanan Laxminarayan, Affiliate Professor of Global Health at the University of Washington, and Director and Senior Fellow, The Center for Disease Dynamics, Economics & Policy, about modelling the progression of the outbreak, India as a potential new hotspot, as well as when we might feasibly see a vaccine on the market.

The Covid-19 pandemic has placed uncertainty at the forefront. When will cases peak? What kind of a recovery will we see? Will shuttered economies be able to reopen? Amid this global guessing game, we speak to Ramanan Laxminarayan, Affiliate Professor of Global Health at the University of Washington, and Director and Senior Fellow, The Center for Disease Dynamics, Economics & Policy, about modelling the progression of the outbreak, India as a potential new hotspot, as well as when we might feasibly see a vaccine on the market.

Original broadcast date: July 17, 2015. In a world with limited resources, can we find ways to salvage what's disappearing? Can we innovate our way out of a finite landscape? This hour, TED speakers explore ideas about living with less. Guests include ethnobotanist Mark Plotkin, ecologist Jon Foley, economist Ramanan Laxminarayan, community organizer Rob Hopkins, and researcher Navi Radjou.

Have you ever heard of a drug resistant economist? Have you ever thought how economics would intersect with antibiotics? Well, I didn't either until I read an article that Dr.Ramanan Laxminarayan had coauthored. What I read has led me to rethink about the world's drug resistant problems on a much broader scale, including how antibiotics are used in animal agriculture to promote growth. (one more reason to eat plants!) This discussion will challenge how you think about antibiotics and hopefully think twice before insisting on antibiotics at your next doctor's visit when he/she says it is a virus... Dr. Laxminarayan directs the Center for Disease Dynamics, Economics & Policy. He is also a Senior Research Scholar and Lecturer at Princeton University. His research deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems. He has worked to improve understanding of drug resistance as a problem of managing a shared global resource. Laxminarayan has worked with the World Health Organization (WHO) and the World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He has served on a number of advisory committees at WHO, Centers for Disease Control and Prevention, and the Institute of Medicine. This is one of those fascinating conversations I wish could have went longer. This subject affects ALL of us on earth...please share this important message and I hope you learn as much as I did! Thank you for listening like always! Please share the podcast!

Listen to Dr. Ramanan Laxminarayan discuss the practical mechanisms for achieving goals to reduce antibiotic consumption (in humans and animals), and how resources could be best utilized.

Listen to Dr. Laxminarayan discuss the practical mechanisms for achieving goals to reduce antibiotic consumption (in humans and animals), and how resources could be best utilized .

Ramanan Laxminarayan discusses the implications of antibiotic resistance for prophylaxis.

Antibiotics have transformed modern medicine, but their overuse has resulted in more drug–resistant strains of bacteria. As resistance increases, people in poorer countries often can’t afford expensive second-line drugs. Ramanan Laxminarayan, Princeton University and director of the Center for Disease Dynamics, Economics & Policy.

Los antibióticos salvan vidas, pero los utilizamos demasiado y, con frecuencia, no lo hacemos para salvar vidas, sino que los utilizamos para tratar la gripe o criar gallinas. El resultado, afirma el investigador Ramanan Laxminarayan, es que las bacterias que atacamos se vuelven más resistentes y así, los antibióticos están dejando de tener efecto. Laxminarayan nos pide a todos, tanto a pacientes como a médicos, que reflexionemos sobre los antibióticos y su eficacia actual como un recurso limitado y que pensemos dos veces antes de emplearlos. Se trata de una perspectiva aleccionadora sobre cómo las tendencias clínicas globales pueden dañarnos.

Antibiotika retten Leben. Aber wir verwenden sie einfach zu oft – und oftmals für nicht-lebensrettende Zwecke, wie zur Behandlung der Grippe und sogar zur verbilligten Aufzucht von Hühnern. Das Ergebnis ist laut dem Forscher Ramanan Laxminarayan, dass die Medikamente nicht mehr bei jedem wirken werden, da die Bakterien, auf die sie abzielen, immer resistenter werden. Er fordert jeden einzelnen von uns auf (Patienten wie Ärzte), Antibiotika – sowie ihre anhaltende Wirksamkeit – als endlichen Rohstoff zu betrachten und sehr genau zu überlegen, bevor man ihn anzapft. Es ist eine ernüchternde Betrachtung, wie weltweite medizinische Trends nach hinten losgehen können.

Antibióticos salvam vidas. Mas nós simplesmente os utilizamos muito, e muitas vezes, para fins que não o de salvar vidas, como o tratamento da gripe e até mesmo a criação mais barata de galinhas. O resultado, diz o pesquisador Ramanan Laxminarayan, é que os remédios vão parar de funcionar para todos, conforme as bactérias que eles atacam, ficam cada vez mais resistentes. Ele convida todos nós (pacientes e médicos também) a pensar nos antibióticos, e sua eficácia em curso, como um recurso finito, e a pensar duas vezes antes de tomá-los. É um olhar racional sobre como as tendências médicas globais podem nos afetar.

항생제는 생명을 살립니다. 하지만 우리는 이를 과다하게 사용하고 있습니다 - 독감을 치료하거나 닭을 좀 더 싸게 키우는 것과 같은, 생명을 살리는 것과 무관한 용도로 사용하는 일도 허다합니다. 연구원 라마난 락스미나라얀에 의하면, 결과적으로 모두에게 약이 듣지 않게 될 것이라고 합니다. 항생제가 목표로 하는 박테리아가 점점 더 내성이 강해지기 때문입니다. 그는 (환자와 의사를 포함한) 우리 모두에게 항생제와 그 효과를 한정된 자원으로 보고, 사용하기 전에 한 번 더 생각해달라고 얘기합니다. 이는 국제적인 의료 추세가 어떻게 일반 가정에까지 영향을 미칠 수 있는지에 대한 충격적인 관점입니다.

Antibiotic drugs save lives. But we simply use them too much — and often for non-lifesaving purposes, like treating the flu and even raising cheaper chickens. The result, says researcher Ramanan Laxminarayan, is that the drugs will stop working for everyone, as the bacteria they target grow more and more resistant. He calls on all of us (patients and doctors alike) to think of antibiotics -- and their ongoing effectiveness -- as a finite resource, and to think twice before we tap into it. It's a sobering look at how global medical trends can strike home.

Les antibiotiques sauvent des vies. Mais nous les utilisons trop, et souvent pour des raisons qui ne sont pas vitales, comme pour traiter la grippe, ou même pour élever des poulets moins chers. Selon le chercheur Ramanan Laxminarayan, le résultat en est que le médicament ne va plus marcher dans tous les cas, à mesure que la bactérie qu'il cible va devenir de plus en plus résistante. Il nous appelle tous (les patients comme les médecins) à voir les antibiotiques comme une ressource limitée, et à y réfléchir à deux fois avant d'y puiser. Une vision qui donne à réfléchir sur la façon dont les tendances médicales mondiales peuvent nous atteindre personnellement.